Copyright Reports & Markets. All rights reserved.

Global Type 2 Diabetes Medication Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Type 2 Diabetes Medication Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Type 2 Diabetes Medication Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Biguanides
      • 1.4.3 Sulphonylureas
      • 1.4.4 Thiazolidinediones
      • 1.4.5 Alpha-glucosidase Inhibitors
      • 1.4.6 DPP-4 Inhibitors
      • 1.4.7 GLP-1 Receptor Agonists
      • 1.4.8 SGLT-2 Inhibitors
      • 1.4.9 Insulins
    • 1.5 Market by Application
      • 1.5.1 Global Type 2 Diabetes Medication Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Type 2 Diabetes Medication Market Perspective (2015-2026)
    • 2.2 Type 2 Diabetes Medication Growth Trends by Regions
      • 2.2.1 Type 2 Diabetes Medication Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Type 2 Diabetes Medication Historic Market Share by Regions (2015-2020)
      • 2.2.3 Type 2 Diabetes Medication Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Type 2 Diabetes Medication Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Type 2 Diabetes Medication Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Type 2 Diabetes Medication Players by Market Size
      • 3.1.1 Global Top Type 2 Diabetes Medication Players by Revenue (2015-2020)
      • 3.1.2 Global Type 2 Diabetes Medication Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Type 2 Diabetes Medication Market Concentration Ratio
      • 3.2.1 Global Type 2 Diabetes Medication Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Medication Revenue in 2019
    • 3.3 Type 2 Diabetes Medication Key Players Head office and Area Served
    • 3.4 Key Players Type 2 Diabetes Medication Product Solution and Service
    • 3.5 Date of Enter into Type 2 Diabetes Medication Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Type 2 Diabetes Medication Historic Market Size by Type (2015-2020)
    • 4.2 Global Type 2 Diabetes Medication Forecasted Market Size by Type (2021-2026)

    5 Type 2 Diabetes Medication Breakdown Data by Application (2015-2026)

    • 5.1 Global Type 2 Diabetes Medication Market Size by Application (2015-2020)
    • 5.2 Global Type 2 Diabetes Medication Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Type 2 Diabetes Medication Market Size (2015-2020)
    • 6.2 Type 2 Diabetes Medication Key Players in North America (2019-2020)
    • 6.3 North America Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 6.4 North America Type 2 Diabetes Medication Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Type 2 Diabetes Medication Market Size (2015-2020)
    • 7.2 Type 2 Diabetes Medication Key Players in Europe (2019-2020)
    • 7.3 Europe Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 7.4 Europe Type 2 Diabetes Medication Market Size by Application (2015-2020)

    8 China

    • 8.1 China Type 2 Diabetes Medication Market Size (2015-2020)
    • 8.2 Type 2 Diabetes Medication Key Players in China (2019-2020)
    • 8.3 China Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 8.4 China Type 2 Diabetes Medication Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Type 2 Diabetes Medication Market Size (2015-2020)
    • 9.2 Type 2 Diabetes Medication Key Players in Japan (2019-2020)
    • 9.3 Japan Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 9.4 Japan Type 2 Diabetes Medication Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Type 2 Diabetes Medication Market Size (2015-2020)
    • 10.2 Type 2 Diabetes Medication Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Type 2 Diabetes Medication Market Size by Application (2015-2020)

    11 India

    • 11.1 India Type 2 Diabetes Medication Market Size (2015-2020)
    • 11.2 Type 2 Diabetes Medication Key Players in India (2019-2020)
    • 11.3 India Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 11.4 India Type 2 Diabetes Medication Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Type 2 Diabetes Medication Market Size (2015-2020)
    • 12.2 Type 2 Diabetes Medication Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Type 2 Diabetes Medication Market Size by Type (2015-2020)
    • 12.4 Central & South America Type 2 Diabetes Medication Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 AstraZeneca
      • 13.1.1 AstraZeneca Company Details
      • 13.1.2 AstraZeneca Business Overview and Its Total Revenue
      • 13.1.3 AstraZeneca Type 2 Diabetes Medication Introduction
      • 13.1.4 AstraZeneca Revenue in Type 2 Diabetes Medication Business (2015-2020))
      • 13.1.5 AstraZeneca Recent Development
    • 13.2 Novartis
      • 13.2.1 Novartis Company Details
      • 13.2.2 Novartis Business Overview and Its Total Revenue
      • 13.2.3 Novartis Type 2 Diabetes Medication Introduction
      • 13.2.4 Novartis Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.2.5 Novartis Recent Development
    • 13.3 Novo Nordisk
      • 13.3.1 Novo Nordisk Company Details
      • 13.3.2 Novo Nordisk Business Overview and Its Total Revenue
      • 13.3.3 Novo Nordisk Type 2 Diabetes Medication Introduction
      • 13.3.4 Novo Nordisk Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.3.5 Novo Nordisk Recent Development
    • 13.4 Johnson & Johnson
      • 13.4.1 Johnson & Johnson Company Details
      • 13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
      • 13.4.3 Johnson & Johnson Type 2 Diabetes Medication Introduction
      • 13.4.4 Johnson & Johnson Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.4.5 Johnson & Johnson Recent Development
    • 13.5 Boehringer Ingelheim
      • 13.5.1 Boehringer Ingelheim Company Details
      • 13.5.2 Boehringer Ingelheim Business Overview and Its Total Revenue
      • 13.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Introduction
      • 13.5.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.5.5 Boehringer Ingelheim Recent Development
    • 13.6 Bristol-Myers Squibb
      • 13.6.1 Bristol-Myers Squibb Company Details
      • 13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
      • 13.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Introduction
      • 13.6.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.6.5 Bristol-Myers Squibb Recent Development
    • 13.7 Eli Lilly
      • 13.7.1 Eli Lilly Company Details
      • 13.7.2 Eli Lilly Business Overview and Its Total Revenue
      • 13.7.3 Eli Lilly Type 2 Diabetes Medication Introduction
      • 13.7.4 Eli Lilly Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.7.5 Eli Lilly Recent Development
    • 13.8 Merck
      • 13.8.1 Merck Company Details
      • 13.8.2 Merck Business Overview and Its Total Revenue
      • 13.8.3 Merck Type 2 Diabetes Medication Introduction
      • 13.8.4 Merck Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.8.5 Merck Recent Development
    • 13.9 Sanofi
      • 13.9.1 Sanofi Company Details
      • 13.9.2 Sanofi Business Overview and Its Total Revenue
      • 13.9.3 Sanofi Type 2 Diabetes Medication Introduction
      • 13.9.4 Sanofi Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.9.5 Sanofi Recent Development
    • 13.10 Pfizer
      • 13.10.1 Pfizer Company Details
      • 13.10.2 Pfizer Business Overview and Its Total Revenue
      • 13.10.3 Pfizer Type 2 Diabetes Medication Introduction
      • 13.10.4 Pfizer Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 13.10.5 Pfizer Recent Development
    • 13.11 Astellas Pharma
      • 10.11.1 Astellas Pharma Company Details
      • 10.11.2 Astellas Pharma Business Overview and Its Total Revenue
      • 10.11.3 Astellas Pharma Type 2 Diabetes Medication Introduction
      • 10.11.4 Astellas Pharma Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.11.5 Astellas Pharma Recent Development
    • 13.12 Daiichi Sankyo
      • 10.12.1 Daiichi Sankyo Company Details
      • 10.12.2 Daiichi Sankyo Business Overview and Its Total Revenue
      • 10.12.3 Daiichi Sankyo Type 2 Diabetes Medication Introduction
      • 10.12.4 Daiichi Sankyo Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.12.5 Daiichi Sankyo Recent Development
    • 13.13 Biocon
      • 10.13.1 Biocon Company Details
      • 10.13.2 Biocon Business Overview and Its Total Revenue
      • 10.13.3 Biocon Type 2 Diabetes Medication Introduction
      • 10.13.4 Biocon Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.13.5 Biocon Recent Development
    • 13.14 Glenmark
      • 10.14.1 Glenmark Company Details
      • 10.14.2 Glenmark Business Overview and Its Total Revenue
      • 10.14.3 Glenmark Type 2 Diabetes Medication Introduction
      • 10.14.4 Glenmark Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.14.5 Glenmark Recent Development
    • 13.15 Bayer AG
      • 10.15.1 Bayer AG Company Details
      • 10.15.2 Bayer AG Business Overview and Its Total Revenue
      • 10.15.3 Bayer AG Type 2 Diabetes Medication Introduction
      • 10.15.4 Bayer AG Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.15.5 Bayer AG Recent Development
    • 13.16 Takeda
      • 10.16.1 Takeda Company Details
      • 10.16.2 Takeda Business Overview and Its Total Revenue
      • 10.16.3 Takeda Type 2 Diabetes Medication Introduction
      • 10.16.4 Takeda Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.16.5 Takeda Recent Development
    • 13.17 Sun pharma
      • 10.17.1 Sun pharma Company Details
      • 10.17.2 Sun pharma Business Overview and Its Total Revenue
      • 10.17.3 Sun pharma Type 2 Diabetes Medication Introduction
      • 10.17.4 Sun pharma Revenue in Type 2 Diabetes Medication Business (2015-2020)
      • 10.17.5 Sun pharma Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Type 2 Diabetes Medication status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Type 2 Diabetes Medication development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AstraZeneca
      Novartis
      Novo Nordisk
      Johnson & Johnson
      Boehringer Ingelheim
      Bristol-Myers Squibb
      Eli Lilly
      Merck
      Sanofi
      Pfizer
      Astellas Pharma
      Daiichi Sankyo
      Biocon
      Glenmark
      Bayer AG
      Takeda
      Sun pharma

      Market segment by Type, the product can be split into
      Biguanides
      Sulphonylureas
      Thiazolidinediones
      Alpha-glucosidase Inhibitors
      DPP-4 Inhibitors
      GLP-1 Receptor Agonists
      SGLT-2 Inhibitors
      Insulins
      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Type 2 Diabetes Medication status, future forecast, growth opportunity, key market and key players.
      To present the Type 2 Diabetes Medication development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Type 2 Diabetes Medication are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now